Notes/ObservationsNiikei225 Index registers biggest 1-day percentage decline since May 2012 following the JPY's retracement; China and Hong Kong move off worst levels into their...
Ireland Set To Sell Bills In Return For Markets Since Entering Bailout ConditionsEconomic Data(EU) ECB: €303M borrowed in overnight loan facility (lowest level since late...
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.
| Average | 6.968 (+491.052% Upside) |
| High | 33.201 |
| Low | 1.100 |
| Price | 1.179 |
| No. of Analysts | 6 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Buy | Strong Buy | Strong Buy | Buy |
| Technical Indicators | Strong Sell | Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Neutral | Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 6.71 | 6.79 | 6.63 | -0.13 | -1.90% | 22.96K | OTC Markets | |||
| 320.60 | 322.63 | 319.67 | +1.58 | +0.50% | 3.00M | NYSE | |||
| 12.57 | 12.64 | 12.48 | -0.01 | -0.04% | 67.76K | NYSE | |||
| 0.0209 | 0.0209 | 0.0209 | -0.0016 | -7.24% | 100.00 | OTC Markets | |||
| 0.0001 | 0.0001 | 0.0001 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 34.98 | 35.02 | 34.73 | +0.64 | +1.86% | 36.81K | OTC Markets | |||
| 0.015 | 0.015 | 0.015 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 0.00355 | 0.00355 | 0.0033 | +0.00010 | +2.90% | 6.61M | OTC Markets | |||
| 0.0367 | 0.0367 | 0.0367 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 3.28 | 3.32 | 3.17 | +0.06 | +1.86% | 80.66K | NASDAQ | |||
| 59.00 | 60.40 | 58.97 | -0.30 | -0.51% | 10.09M | NYSE | |||
| 35.50 | 35.64 | 34.92 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 25.54 | 25.55 | 25.54 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 0.0001 | 0.0001 | 0.0001 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 24.24 | 24.25 | 24.23 | 0.00 | 0.00% | 0.00 | NASDAQ |